학술논문

Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.
Document Type
Article
Source
Histopathology. May2011, Vol. 58 Issue 6, p875-885. 11p. 1 Color Photograph, 4 Charts, 1 Graph.
Subject
*NEOVASCULARIZATION
*IMMUNE response
*SKIN cancer
*KIDNEY transplantation
*IMMUNOHISTOCHEMISTRY
Language
ISSN
0309-0167
Abstract
Mackenzie K A, Miller A P, Hock B D, Gardner J, Simcock J W, Roake J A, Dachs G U, Robinson B A & Currie M J (2011) Histopathology , 875-885 The aim of this study was to determine the contribution of tumour angiogenesis to the aggressive growth of non-melanoma skin cancers (NMSCs) in renal transplant recipients (RTRs). The study cohort included RTRs ( n = 38) with formalin-fixed paraffin-embedded tumour samples available from first post-transplant NMSC (NMSC1) surgically excised at Christchurch Hospital, New Zealand, from 1997 to 2007. Comparable samples excised from immunocompetent individuals (ICIs) ( n = 36) were selected to accommodate confounding factors. Markers of tumour angiogenesis were evaluated by immunohistochemistry, and analysed for associations with clinicopathological variables. As compared with ICIs, RTRs had a higher proportion of tumours with high microvessel density ( P = 0.008), high proliferating capillary index ( P < 0.0001) and low microvessel pericyte coverage index ( P < 0.0001), and RTRs had a shorter cumulative second NMSC (NMSC2)-free interval ( P < 0.0001). ICIs had a higher proportion of tumours with a 'marked' number of vascular endothelial growth factor (VEGF)-A-positive leukocytes than RTRs ( P = 0.04), and RTRs with a 'moderate/marked' number of VEGF-A-positive leukocytes had longer cumulative NMSC2-free intervals than those with a 'minimum' number ( P = 0.02). This study demonstrates increased tumour angiogenesis in NMSC in RTRs, and suggests a role for VEGF-A-positive peritumoural leukocytes in suppressing NMSC development. [ABSTRACT FROM AUTHOR]